Tue, Aug 13, 2024
What will be the impact of changes in MSCI index?, Is there a buying opportunity in HDFC Bank?, Why do profit booking in Zydus Life?, Buy Vodafone Idea today?, Know from Anil Singhvi.
More >
Mon, Jul 22, 2024
Mexican regulatory authority COFEPRIS (Federal Commission for the Protection Against Sanitary Risk), has granted marketing approval for Bhava, a Bevacizumab biosimilar and it will be marketed in different strengths of 100 mg/4 ml and 400 mg/16 ml, Zydus Lifesciences said in a regulatory filing.
Thu, Jul 04, 2024
Stock In Action: Rise in Zydus Life. The results in Q1FY25 will be very strong. Pharma sector is expected to have stronger than average growth and will benefit from strong export sales.
Mon, Apr 22, 2024
Zydus is among the first suppliers to launch the generic version of Mirabegron extended-release tablets (USP 25 mg) in the US market.
Fri, Feb 09, 2024
The drugmaker had reported a net profit of Rs 623 crore in the October-December period a year ago.Revenue increased to Rs 4,505 crore in the third quarter from Rs 4,257 crore in the year-ago period, Zydus Lifesciences said in a statement.
Tue, Feb 06, 2024
Zydus Life said on Monday that it would consider a proposal for buyback of fully paid-up equity shares of the company. The Zydus stock also hit a 52-week high on February 1 and 5, and January 30 and 31.
Fri, Aug 18, 2023
The NSE Indices Committee has made changes to the Nifty Next50, Nifty Midcap 150, and Nifty Smallcap 100 indices. Nykaa, HDFC AMC, Indus Towers, Page Industries, and ACC have been removed from the Nifty Next50, while PNB, Shriram Finance, Trent, TVS Motor, and Zydus Life have been added.
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
